Cytori Therapeutics reported $-5219000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Cerus CERS:US USD -8454000 137K
Cytori Therapeutics CYTX:US USD -5219000 63K
Dr.Reddys Laboratories DRRD:IN INR 16.16B 1.48B
Infinity Pharmaceuticals INFI:US USD -10717000 1.27M
Mirati Therapeutics MRTX:US USD -173307000 3.14M
Sun Pharmaceuticals SUNP:IN INR 24.12B 1.28B
Teva Pharmaceutical TEVA:IT USD 768M 1.93B